Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 15, 2025Glavvrač (Chief Medical Officer)

Side effects of SGLT-2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

ESE. N. SaykinaМMМ. L. MaksimovБРБ. К. Романов

Discussion

Loading...

Member takes

Overview

This review outlines side effects and benefits of sglt-2 inhibitors, suggesting promising implications for diabetes treatment with comorbidities.

Key Points

  • SGLT-2 inhibitors provide valuable cardioprotective and nephroprotective effects alongside their hypoglycemic action.
  • Common side effects include dehydration, glycosuria, and fungal infections, with more serious outcomes like acute kidney injury.
  • Assessment of side effects helps in understanding their impact on diabetic patients with potential comorbidities.
  • Preventive recommendations for adverse reactions associated with SGLT-2 inhibitors are crucial for safe usage.

Cite This Study

Saykina et al. (2025) studied this question.

synapsesocial.com/papers/68af59d2ad7bf08b1eade338https://doi.org/10.33920/med-03-2508-02
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Meta-analysis of the efficacy and safety of SGLT-2 inhibitors in patients with heart failure and type 2 diabetes mellitus2025 · 4 citations
  2. 2A study on the pharmacovigilance of various SGLT-2 inhibitors2025 · 6 citations
  3. 3Management of SGLT-2 Inhibitors in the Perioperative Period: Withhold or Continue?2025 · 4 citations
  4. 4Risk of acute kidney injury in dapagliflozin users with type 2 diabetes: A nationwide propensity score‐matched cohort study in Korea2025 · 1 citations
  5. 5Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow)2022 · 5 citations